Walgreens agrees to acquire assets of 12 Eaton Apothecary pharmacies
DEERFIELD, Ill. One of the nation’s largest drug store chains has signed a definitive agreement to acquire the assets of a local pharmacy chain.
Walgreens announced Friday evening that it would acquire the assets of 12 Eaton Apothecary pharmacies in the Boston area from D.A.W. Inc., a subsidiary of Nyer Medical Group Inc. The transaction is valued at approximately $19 million.
“Today is a very special day for our Boston market,” said Dave White, Walgreens market VP for Boston on Friday. “Not only are we keeping most of the pharmacies open, but we also intend for eligible employees at all 12 locations to join our team. Eaton’s customers should expect to see the familiar faces and services they know and trust, while benefiting from Walgreens expanded product and service offering. We look forward to continuing Eaton’s 100-plus year tradition of quality pharmacy service in communities around the Boston area.”
The acquisition is subject to certain terms and conditions, and is expected to close within the next 90 days.
“I am happy to say that Walgreens interest in Eaton’s has been beyond buying only prescription files – they will continue to operate a majority of the 12 stores as well as hire all eligible employees from the 12 locations,” said Mark Dumouchel, president of D.A.W and Nyer Medical Group. “I am confident that the best choice for our customers and employees is Walgreens.”
Hy-Vee celebrates the other white meat
WEST DES MOINES, Iowa A lot of people complain about pork barrel spending, but not Midwest supermarket chain Hy-Vee.
October is National Pork Month, and the West Des Moines, Iowa-based Hy-Vee announced Friday that sales of the meat have increased more than 25% over October 2008. The chain said it was on track to increase pork tonnage by more than 30%.
“With pork prices the lowest they’ve been in more than a decade, we’ve focused our marketing efforts on promoting pork as a great value for consumers,” Hy-Vee assistant VP meat operations Kenan Judge said in a statement. “Today’s shopper is looking for nutritious, economical meal ideas, and pork perfectly fits the bill.”
Patients prefer new diabetes drug Victoza over its competitor, survey finds
MONTREAL A new diabetes drug satisfied patients more than its competitor, according to a study funded by the drug’s manufacturer.
According to data on 379 patients who took the Diabetes Treatment Satisfaction Questionnaires, presented Thursday at the 20th World Diabetes Congress and published in medical journal The Lancet, patients taking Novo Nordisk’s drug Victoza (liraglutide) perceived less abnormally low or high blood sugar levels — known respectively as hypoglycemia and hyperglycemia — than those taking Byetta (exenatide), made by Eli Lilly & Co., Amylin Corp. and Alkermes.
Victoza is approved in Europe, but Novo Nordisk is still waiting for approval from the Food and Drug Administration in the United States.
“Liraglutide has shown here in a convincing study that it is associated with less nausea, less perceived hypoglycemia and definitely higher patient satisfaction compared to exenatide,” principal investigator Wolfgang Schmidt said in a statement. “Patient-reported outcomes data is an important extension of the efficacy data. If a patient is satisfied with his or her treatment, then they are much more likely to really stick to the treatment over the long term, which is necessary in Type 2 diabetes.”